Xtl Biopharmaceuticals (XTLB) Income from Non-Controlling Interests (2011 - 2015)
Xtl Biopharmaceuticals (XTLB) posted Income from Non-Controlling Interests of -$1.35 million for the year ended Dec 31, 2019, compared with $2.99 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Income from Non-Controlling Interests (2011 - 2015) Analysis & Trends
Since the year ended Dec 31, 2010, Xtl Biopharmaceuticals has reported Income from Non-Controlling Interests for 10 years.
- The figure for the year ended Dec 31, 2019 stands as the lowest annual Income from Non-Controlling Interests since the year ended Dec 31, 2016.
- Business Quant data shows XTLB's Income from Non-Controlling Interests at $2.99 million in the year ended Dec 31, 2018, -$781,000 in the year ended Dec 31, 2017, -$2.55 million in the year ended Dec 31, 2016 and $2,000 in the year ended Dec 31, 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | 2,000.00 |
| Dec 31, 2014 | -58,000.00 |
| Sep 30, 2014 | -58,000.00 |
| Jun 30, 2014 | -147,000.00 |
| Mar 31, 2014 | -75,000.00 |
| Dec 31, 2013 | -662,000.00 |
| Sep 30, 2013 | -104,000.00 |
| Jun 30, 2013 | -241,000.00 |
| Mar 31, 2013 | -230,000.00 |
| Dec 31, 2012 | -252,000.00 |
| Sep 30, 2012 | -100,000.00 |
| Jun 30, 2012 | -82,000.00 |
| Mar 31, 2012 | -103,000.00 |
| Dec 31, 2011 | 67,000.00 |
| Sep 30, 2011 | -133,000.00 |
| Jun 30, 2011 | -134,000.00 |
API Access
Xtl Biopharmaceuticals Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();